NCT01985724 2014-05-14Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast CancerHellenic Oncology Research GroupPhase 3 Completed650 enrolled